MicroRNA-577 inhibits the migration and invasion of hepatocellular carcinoma cells by targeting homeobox A1

被引:11
作者
Han, Shaoshan [1 ]
Liu, Zhikui [1 ]
Wang, Yufeng [1 ]
Wang, Liang [1 ]
Yao, Bowen [1 ]
Guo, Cheng [1 ]
Song, Tao [1 ]
Tu, Kangsheng [1 ]
Liu, Qingguang [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; miR-577; HOXA1; EMT; metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-GROWTH; HOXA1; MIR-577; METASTASIS; SURVIVAL; EMT;
D O I
10.3892/or.2018.6388
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Research has confirmed that abnormally expressed miRNAs are involved in the occurrence and development of hepatocellular carcinoma (HCC). In the present study, we confirmed that miR-577 expression both in HCC tissues and cell lines was markedly downregulated. Clinically, downregulated expression of miR-577 is notably related to malignant clinicopathological features, such as venous invasion and advanced TNM stage. Additionally, miR-577 may act as a valuable tumor marker to predict the prognosis of HCC patients. Through knockdown and overexpression of miR-577, miR-577 was identified as an inhibitor of cell metastatic ability and EMT progress in HCC. Furthermore, miR-577 was able to directly bind to the 3-UTR of homeobox A1 (HOXA1) to regulate the expression of HOXA1. In addition, there existed a negative correlation between the expression of miR-577 and HOXA1 in HCC specimens. Rescue experiments revealed that the influence of miR-577 on the migration, invasion and EMT of HCC cells was reversed by HOXA1. Taken together, our findings demonstrated that miR-577 functions as an anti-oncogene to suppress the migration, invasion and EMT of HCC cells through direct interaction with HOXA1. miR-577 may act as a valuable target for the molecular-targeted therapy of HCC.
引用
收藏
页码:2987 / 2995
页数:9
相关论文
共 31 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   miR-577 inhibits pancreatic β-cell function and survival by targeting fibroblast growth factor 21 (FGF-21) in pediatric diabetes [J].
Chen, X. Y. ;
Li, G. M. ;
Dong, Q. ;
Peng, H. .
GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) :15462-15470
[3]   miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4 [J].
Dou, Changwei ;
Liu, Zhikui ;
Xu, Meng ;
Jia, Yuli ;
Wang, Yufeng ;
Li, Qing ;
Yang, Wei ;
Zheng, Xin ;
Tu, Kangsheng ;
Liu, Qingguang .
CANCER LETTERS, 2016, 381 (02) :380-390
[4]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576
[5]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[6]  
Garzon R, 2009, ANNU REV MED, V60, P167, DOI [10.1146/annurev.med.59.053006.104707, 10.1146/annurev.pathol.4.110807.092222]
[7]   The role of epithelial-mesenchymal transition in cancer pathology [J].
Guarino, Marcello ;
Rubino, Barbara ;
Ballabio, Gianmario .
PATHOLOGY, 2007, 39 (03) :305-318
[8]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
[9]   Deep Sequencing of RNA from Three Different Extracellular Vesicle (EV) Subtypes Released from the Human LIM1863 Colon Cancer Cell Line Uncovers Distinct Mirna-Enrichment Signatures [J].
Ji, Hong ;
Chen, Maoshan ;
Greening, David W. ;
He, Weifeng ;
Rai, Alin ;
Zhang, Wenwei ;
Simpson, Richard J. .
PLOS ONE, 2014, 9 (10)
[10]   microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer [J].
Jiang, Haiping ;
Ju, Hui ;
Zhang, Lin ;
Lu, Haijun ;
Jie, Kan .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (06)